1Yokosukao, Omata M, Imazeki F, et al. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interfere on treatment: analysis of intra hepatitic replicative hepatitis B virus DNA[J ]. Hepatology, 1985,5:728～ 734.
2Evens F, Main J, Honkoo P, et al. Lamivud in etherapy for chronic hepatitis B: a six month and omized dose ranging study[J]. Gastoenterology, 1997,113:1258～ 1263.
3Fu L, Cheng YC. Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L. SddC (3TC)resistance[J]. Biochem Pharmacol, 1998,55:1567～1572.
4Wright TL,Lau JY. Clinical aspects of hepatitis B virus infection[ J ]. Lancet, 1993,342:1340 - 1344.
5Lai CL,Chien RN,Leung NW, et al. Alyeartrial of lamivudine for chronic hepatitis B [J]. Nengl J Med, 1998,339:61～68.
9Sell MA ,Chen ML,Acs G. Production of hepatitis B virus particles in HePG2 cells transfected with cloned hepatitis B virus DNA[J]. Pro Notl Acad Sci USA, 1987,84:1005～1009.
